Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein
Authors
Keywords
-
Journal
JOURNAL OF LIPID RESEARCH
Volume 56, Issue 5, Pages 972-985
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-02-05
DOI
10.1194/jlr.m054635
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects
- (2014) Andreas Gille et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol Efflux Capacity, Carotid Atherosclerosis, and Cerebrovascular Symptomatology
- (2014) R.J. Doonan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-Density Lipoprotein
- (2014) Thomas F. Lüscher et al. CIRCULATION RESEARCH
- ATP-Binding Cassette Transporters, Atherosclerosis, and Inflammation
- (2014) Marit Westerterp et al. CIRCULATION RESEARCH
- Novel Therapies Focused on the High-Density Lipoprotein Particle
- (2014) Julian C. van Capelleveen et al. CIRCULATION RESEARCH
- Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
- (2014) J.-C. Tardif et al. EUROPEAN HEART JOURNAL
- Molecular Mechanisms of Cellular Cholesterol Efflux
- (2014) Michael C. Phillips JOURNAL OF BIOLOGICAL CHEMISTRY
- Imaging and Nanomedicine in Inflammatory Atherosclerosis
- (2014) W. J. M. Mulder et al. Science Translational Medicine
- High-Density Lipoprotein Mediated Cellular Cholesterol Efflux in Acute Coronary Syndromes
- (2013) Anouar Hafiane et al. AMERICAN JOURNAL OF CARDIOLOGY
- Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux
- (2013) Svetlana Diditchenko et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Liver ABCA1 Deletion in LDLrKO Mice Does Not Impair Macrophage Reverse Cholesterol Transport or Exacerbate Atherogenesis
- (2013) Xin Bi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Importance of Evaluating Cell Cholesterol Influx With Efflux in Determining the Impact of Human Serum on Cholesterol Metabolism and Atherosclerosis
- (2013) Ginny L. Weibel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Future of High-Density Lipoprotein Infusion Therapies
- (2013) Bronwyn A. Kingwell et al. CIRCULATION
- Genetics of HDL-C: A Causal Link to Atherosclerosis?
- (2013) Julian C. van Capelleveen et al. Current Atherosclerosis Reports
- High-density lipoproteins for the systemic delivery of short interfering RNA
- (2013) Kaylin Marie McMahon et al. Expert Opinion on Drug Delivery
- Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability
- (2013) Nicholas N. Lyssenko et al. FASEB JOURNAL
- Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphate-enriched Plasma High Density Lipoprotein
- (2013) Mingxia Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys
- (2013) Herman J. Kempen et al. JOURNAL OF LIPID RESEARCH
- Cardioprotective functions of HDLs
- (2013) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
- Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies
- (2013) Eun Jung Cho et al. MOLECULAR PHARMACEUTICS
- Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery
- (2012) Marina G. Damiano et al. ADVANCED DRUG DELIVERY REVIEWS
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- Myeloid Cell−Specific ABCA1 Deletion Protects Mice From Bacterial Infection
- (2012) Xuewei Zhu et al. CIRCULATION RESEARCH
- New insights into the determination of HDL structure by apolipoproteins
- (2012) Michael C. Phillips JOURNAL OF LIPID RESEARCH
- Tailoring of Biomimetic High-Density Lipoprotein Nanostructures Changes Cholesterol Binding and Efflux
- (2011) Andrea J. Luthi et al. ACS Nano
- HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
- (2011) R. S. Rosenson et al. CLINICAL CHEMISTRY
- Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein
- (2011) Anh Hoang et al. EUROPEAN HEART JOURNAL
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
- (2011) Kasey C. Vickers et al. NATURE CELL BIOLOGY
- Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma
- (2011) Rong Huang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
- (2010) Margarita de la Llera-Moya et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Small Discoidal Pre-β1 HDL Particles Are Efficient Acceptors of Cell Cholesterol via ABCA1 and ABCG1
- (2009) Elda Favari et al. BIOCHEMISTRY
- Templated Spherical High Density Lipoprotein Nanoparticles
- (2009) C. Shad Thaxton et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
- (2008) James A. Shaw et al. CIRCULATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started